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Abstract 
Purpose: To investigate the distribution of methionine synthase A2756G (MSA2756G) in the 
hypertensive patients in northwest Chinese population.   
Methods: A total of 378 unrelated hypertensive patients attending Ningxia Peoples Hospital, Ningxia 
Province, China, were recruited for this study. We analyzed genotype by amplication - created 
restriction sites (ACRS) and polymerase chain reaction - restrict fragment length polymorphism (PCR - 
RFLP) in hypertensive patients, and inspected the relation of the genotype with hypertension by χ2 and t 
test.   
Results: The frequency of G allele was 10.25 % in the control group and 14.04 % in hypertension 
group; it was not statistically different (p > 0.05). In the male group, the frequency of allele G was 11.50 
% in control group, and 8.79 % in hypertension group. There was no significant difference between 
control and hypertension groups (p > 0.05). In the female group, the frequency of allele G was 9.00 %, 
in control and 19.54 % in hypertension group (p < 0.05), while in the hypertension group, allele G was 
8.79 % in males which is significantly lower (p < 0.05) than in females (19.54 %) .  
Conclusion: Allele G of MSA2756G is a risk factor for hypertension in female in this Chinese 
population of this study. 
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Hypertension is a major global public health 
problem due to its high prevalence and its 
association with morbidity and mortality from 
stroke and coronary diseases [1,2]. In China, it 
was reported that 27.2 % of adults aged 35 - 74 
years suffer from hypertension [3]. High blood 
pressure is regarded as a complex condition to 
which genetic, environmental, and demographic 
factors contribute interactively [4].  
 
To date, there have been many studies to search 
for hypertension susceptibility genes, but only 
little information about it is available. In order to 
determine the pathogenesis of hypertension and 
to device a novel treatment method, it is 
essential to find new genes associated with 
hypertension.  
 
Methionine synthase (MS) is a key enzyme in the 
homocysteine (Hcy) re - methylation pathway. 
Genetic variations of MS genes may significantly 
affect Hcy metabolism. An enhanced function of 
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MS will lead to a decreased plasma Hcy level. An 
A - to - G substitution of the MS gene 
(MSA2756G), which results in the conversion of 
an aspartic acid residue to a glycine residue, was 
found to play a role in regulating plasma Hcy 
levels [5]. Hcy was also found to be associated 
with blood pressure levels in several studies [5-
8]. In the light of these findings, MS gene 
polymorphism might also be a possible 
underlying mechanism in blood pressure.  
 
MSA2756G gene seems to be an attractive 
candidate gene for hypertension. In the present 
study, our aims were to investigate the 
association between MSA2756G and the risk of 






In all, 378 unrelated Chinese (187 females, 191 
males) were randomly recruited at Ningxia 
Peoples Hospital in Ningxia Province, China, 
including 178 hypertensive patients (87 females, 
91 males; mean age 46.06 ± 6.90 years) and 200 
healthy volunteers (100 females, 100 males; 
mean age 46.22 ± 9.25 years). All subjects 
completed a standard questionnaire on personal 
medical history and family history of 
hypertension. Hypertension was defined as 
mean systolic blood pressure (SBP) ≥ 140 
mmHg and/or mean diastolic blood pressure 
(DBP) ≥ 90 mmHg and/or self - reported current 
treatment for hypertension with antihypertensive 
medication. Subjects with secondary 
hypertension, primary renal disease, diabetes 
mellitus, hepatic disorders, cancers or endocrine 
diseases were excluded. This study complied 
with Declaration of Helsinki [9]. All participants 
involved gave their written informed consent for 
the genetic analysis and the study was approved 
by the Ethics Committee of Ningxia Peoples 




Genomic DNA was extracted from white blood 
cells via phenol and chloroform extraction and 
ethanol precipitation essentially following 
standard protocols. MSA2756G genotype was 
determined by means of PCR - RFLP. Primers 
for PCR were all synthesized by GeneCore Bio 
Technologies (Shang Hai, China). The 
sequences and reverse primers used were 5' - 
CATGGAAGAATATGAAGATATTAGAC - 3' and 
5' - GAACTAGAAGACAGAAATTCTCTA - 3'. 
PCR was performed using 50 ng DNA as a 
template under the following conditions: 94 °C for 
5 min, then 35 cycles of 94 °C for 50 s, an 
annealing temperature at 56 °C for 60 s, and 
extension at 72 °C for 1 min, with a final 
extension at 72 °C for 7 min. The amplified DNA 
fragment was digested with restriction enzymes 
Hae at 37 °C for 12 h. The DNA fragments of 
MSA2756G was separated by 4 % agarose gel 





Statistical analysis was performed using SPSS 
11.5 software. The results are expressed as 
mean ± standard deviation (SD). Allele 
frequencies were compared by Chi - square test 
with Yates’ correction, while an independent t - 
test was used to compare the two groups. P < 




Characteristics of the subjects 
 
The clinical and laboratory characteristics of 
cases and controls were shown in Table 1. The 
subjects were adequately matched for age and 
gender for hypertensive cases and controls. The 
following variables were significantly higher in 
hypertensive patients: SBP, DBP. No significant 
differences were found for the following values 
between the hypertensive patients and the 
control subjects: age, number of the subjects. 
 
MSA2756G genotype and allele frequencies in 
hypertensive patients and healthy control 
 
As shown in Table 2, The MS 2756G allele 
frequency in our study was 12.04 %. G frequency 
was higher in hypertensive patients (14.04 %) 
compared to the control (10.25 %, p > 0.05), 
 
       Table 1: Characteristics of hypertensive patients and healthy control (mean ± SD) 
 
Variable Hypertensive patients Healthy control 
Number（male/female） 178（91/87） 200（100/100） 
Mean age（years） 46.06±6.90 46.22±9.25 
SBP(mmHg) 149.10±15.04 103.63±5.58* 
DBP (mmHg) 95.26±10.75 72.23±2.45* 
          Compared with control, *p < 0.01 
Wang et al 
Trop J Pharm Res, September 2016; 15(9): 1997  
 
Table 2: Frequencies of genotypes and alleles of MSA2756G in hypertensive patients and healthy control 
 
Group Genotype  Allele AA（%） AG（%）  GG (%）  A（%） G（%） 
Hypertensive patients（
n=178） 135 (75.85 %) 36 (20.22 %)  7 (3.93 %)  306 (85.96 %) 50 (14.04 %)
* 
Healthy control（n=200
） 162 (81.00 %) 35 (17.50 %) 3 (1.50 %)
*  359 (89.75 %) 41 (10.25 %) 
*p > 0.05, compared with control 
 
Table 3: Frequencies of genotypes and alleles of MSA2756G in hypertensive patients and healthy control  
 
Gender Group Genotype  Allele 
 AA（%）    AG（%） GG（%）      A（%）    G（%）  
Male Hypertensive patients（
n=91） 
79 (86.81 %) 8 (8.87 %) 4 (4.40 %) 166 (91.21 %) 16 (8.79 %)** 
Healthy control（n=100） 79 (79.00 %) 19 (19.00 %) 2 (2.00 %) 177 (88.50 %) 23 (11.50 %) 
Female Hypertensive patients（
n=87） 
56 (64.37 %) 28 (32.18 %) 3 (3.45 %) 140 (80.46 %) 34 (19.54 
%)* 
Healthy control（n=100） 83 (83.00 %) 16 (16.00 %) 1 (1.00 %) 182 (91.00 %) 18 (9.00 %) 
Compared with control in female group; *p < 0.01, compared with female hypertensive patients, **p < 0.01 
 
the AG + GG genotype frequency in 
hypertensive patients was higher than in those 
with AA genotype compared with control (p > 
0.05), indicating that G allele was not associated 
with hypertension. 
 
Distribution of MSA2756G  
 
A non - significant difference was observed in the 
frequencies of MSA2756G between hypertensive 
patients and healthy control in the male group 
(8.79 % vs 11.50 %, p > 0.05), whereas in the 
female group, the frequency of MSA2756G in 
hypertensive patients was significantly higher 
than that in healthy control (19.54 % vs 9.00 %, p 
< 0.01). Allele G frequency in female group was 
higher than in male group in hypertensive 
patients (19.54 % vs 8.79 %, p < 0.01), whereas 
a non - significant difference was observed in 
healthy control (9.00 % vs 11.50 %, p > 0.05). 
This indicate a gender specific association of 
MSA2756G with hypertension, the allele G of 
MSA2756G was a risk factor for hypertensive 




MS plays an important role in Hcy metabolism as 
a key enzyme in the homocysteine remethylation 
pathway. The MS gene has been cloned, 
sequenced and located, and several 
polymorphisms have also been identified. The 
most prevalent polymorphism is the A2756G 
SNP which results in the conversion of an 
aspartic acid residue to a glycine residue [10]. 
The MS 2756G allele in our Chinese Hui 
population (12.04 %) was similar to the 
frequencies in Singapore (11.0 %) [10], Thailand 
(11.8 %) [11] and Koreans (13.1 %) [12]. The MS 
2756G allele frequency in our study was lower 
than in Japanese (17.3 %) [13], Hispanics (18.8 
%), and Caucasians (19.9 %) [14], which was 
half of that in African Americans (23.8 %) [14] 
and Northern Indians (24 %) [15], Indians (26.4 
%) [10]. The MS 2756G allele is common but 
also heterogeneously distributed among the 
world’s populations. 
 
In this study, we demonstrated that in the female 
group, the frequency of MSA2756G in 
hypertensive patients (19.54 %) was significantly 
higher than that in healthy control (9.00 %), p < 
0.01. In Hypertensive patients, allele G frequency 
in female group was higher than in male group (p 
< 0.01). The present study indicated a gender 
specific association of MSA2756G with 
hypertension, allele G was a risk factor for 
hypertensive disease in female group. A previous 
study found that MS A2756G mutation may be a 
risk factor for combined hyperlipidemia [16]. 
Some studies have indicated that MS 2756G 
allele was related to higher Hcy level, the MS A / 
G or G / G genotype was considered a genetic 
risk factor for elevated Hcy level [10]. D919G 
polymorphism of the MTR gene may be a useful 
genetic marker to predict the antihypertensive 
effect of short - term benazepril therapy in 
hypertensive patient [5,6]. 
 
Arterial hypertension is an important risk factor 
for cardio - and cerebrovascular disease. A 
previous study found significant association the 
MTR c. 2576A > G polymorphism diastolic blood 
pressure [8]. Kahleova et al found that carriers of 
the G - allele of the MTR c. 2756A > G 
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polymorphism had a reduced risk of juvenile 
hypertension [17]. Brett et al found a significant 
effect of methionine loading on diastolic blood 
pressure during exercise resulting in higher 
diastolic blood pressure [18]. The mechanisms 
by which the MS genotype influences diastolic 
blood pressure, but apparently not systolic blood 
pressure, are still unknown.  
 
MS catalyzes the remethylation of homocysteine 
to methionine and has influence on DNA 
methylation as well as on nucleic acid synthesis, 
the missense polymorphism MS c. 2756A > G 
(D919G) has been reported to alter the 
susceptibility to various cancers [19]. In 
summary, our study showed that the allele G of 
MSA2756G was an risk factor for hypertension in 
the female, it  suggest that women carried allele 
G of MSA2756G should be pay more attentions 
in life, in order to prevent from hypertension. 
 
Limitations of the study 
 
In this study, the sample size of participants was 
small, and so the results may be biased; hence, 




The allele G of MSA2756G is a risk factor for 
hypertension in the female Chinese population 
studied, but no association was found with men 
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